2016 American Transplant Congress
Everolimus versus Mycophenolate Mofetil in Combination with Tacrolimus: A Propensity Score Matching Analysis in Liver Transplantation.
Background: No trial has so far investigated everolimus (EVR)-incorporating immunosuppressive regimens versus combined use of tacrolimus (TAC) and mycophenolate mofetil (MMF) in liver transplantation (LT).Materials…2016 American Transplant Congress
Acute Operative Complications and 1,5,& 10 Year Outcomes in Living Donors by Type of Live Donor Nephrectomy – UK Cohort Study.
It is important to have a better understanding of the short and long term outcomes and risks of kidney donation. We studied the occurrence of…2016 American Transplant Congress
KDPI Outcomes and Discard Rates – The Contradiction of the U.S. and European Approach.
Dept. of Nephrology CCM, Charite Berlin, Berlin, Germany.
Introduction: Only a few data exist on the KDPI in European patients (pts). We evaluated the influence of donor factors assessed by the KDPI on…2016 American Transplant Congress
Which Is the Predictable Value of Post-Transplant HCC Recurrence Between Tumor-Related Factors at the Initial Diagnosis and the Transplantation?
Background: Milan criteria is best options to decide whether patients with HCC underwent liver transplantation. However, Milan Criteria is not including values at time of…2016 American Transplant Congress
Predictors of Outcomes After Kidney Transplantation in the Setting of Chronic Opiate Use.
Purpose: To determine the impact and correlation of pre-transplant chronic opiate use with post-transplant chronic opiate use, resource utilization, and patient survival in addition to…2016 American Transplant Congress
Assessment of Postoperative Glycemic Control in Orthotopic Heart Transplant Recipients.
NewYork-Presbyterian Hospital, Columbia University, New York.
Hyperglycemia may occur after solid organ transplantation because of stress, immunosuppressants, and diabetes mellitus. Glycemic control has been shown to decrease morbidity and mortality in…2016 American Transplant Congress
Outcomes for Liver Transplantation Using Organs from Donation After Cardiac Death Donors: A Single Center Experience.
Transplantation, University of Tennessee/Methodist University Transplant Institute, Memphis, TN.
Purpose: The use of donation after cardiac death (DCD) donors provides opportunity to help meet the demand for allografts needed for liver transplantation. However, concern…2016 American Transplant Congress
Hand-Assisted Laparoscopic Donor Nephrectomy: Experience with Over 2400 Cases at a Single Center.
Objective: We reviewed retrospectively the 15 year experience with Hand-Assisted Laparoscopic Donor Nephrectomy (HALDN) at our institution.Methods: 2452 consecutive kidney donors underwent a HALDN between…2016 American Transplant Congress
Single Center Experience with Robotic Kidney Transplantation for Recipients with BMI >40 kg/m2: A Comparison with the UNOS Registry.
Surgery, University of Illinois, Chicago, IL.
Introduction:Obesity represents a barrier to kidney transplantation, but the increasing prevalence amongst renal failure patients has forced some centers to carefully consider such candidates. Morbidly…2016 American Transplant Congress
Deceased Non-A2 Donor ABO-Incompatible Liver Transplantation – Promising Results with Anti-A/B Antibody Reduction Both Pre- and Post-Transplant.
IntroductionOne way to expand the donor pool for patients with acute liver failure could be to use deceased donor (DD) ABO-incompatible (ABOi) liver grafts. However,…
- « Previous Page
- 1
- …
- 126
- 127
- 128
- 129
- 130
- …
- 155
- Next Page »